0%

From the award-winning director of Glen Campbell…I’ll Be Me
A film by James Keach

THE QUEST FOR A CURE

It’s been called the final frontier of medicine, the real health care moonshot, the holy grail of science.

Alzheimer’s disease -- the most feared of all maladies, with no way to cure, stop or even slow its insidious progression.

But now, after decades of perseverance in the lab, researchers are on the cusp of a scientific breakthrough that could be the first step toward making Alzheimer’s itself a distant memory.

In the gripping new documentary Turning Point, acclaimed filmmaker James Keach takes us inside the quest for the first medication that that could treat the underlying process of Alzheimer’s disease, more than a century after Dr. Alois Alzheimer first described the brain disorder that slowly destroys memory and cognitive skills. Along the way, we meet the people behind these grand experiments, the scientists driven as much by personal conviction as professional innovation. And we discover why medical science is never easy, often unpredictable and potentially perilous – and, as America’s preeminent scientist Neil deGrasse Tyson reminds us, always worth the pursuit.

Turning Point follows Keach’s award-winning documentary Glen Campbell…I’ll Be Me, an intimate portrait of music superstar Glen Campbell’s final tour after revealing he had been diagnosed with Alzheimer’s disease. Keach has become a passionate advocate for Alzheimer’s disease research, and after meeting some of the researchers advancing new treatments through clinical trials, committed his storytelling genius to a second film dealing with Alzheimer’s – only this time, it’s the scientists, not the artist, who take center stage.

Turning Point takes on some of the complex issues facing our American healthcare system, including the ongoing debate over the value of medicines. The film also addresses the public health tsunami that will hit the country as Baby Boomers age, with the disease projected to nearly triple in the next 30 years.

CAST

Dr. Paul Aisen Director, USC Alzhiemer’s Therapeutic Research Institute
Los Angeles, CA
Russell Barton Sr. Advisor, Project Management, Eli Lilly and Company
Indianapolis, IN
Dr. Randall Bateman Distinguished Professor of Neurogogy, Washington University
St. Louis, MO
Lauren Emily Brunke Consultant, Project Management, Eli Lilly and Company
Indianapolis, IN
Dr. Goldie Byrd Dean of the College of Arts & Sciences, North Carolina A&T State University
Greensboro, NC
Maria Carrillo Chief Science Officer, Alzheimer’s Association
Chicago, IL
Ron Cohen Founder and CEO, Acorda Therapeutics
Ardsley, NY
Tom Cole Congressman, Oklahoma
Moore, OK
Dr. Jeffrey Cummings Director, Cleveland Clinic, Lou Ruvo Center
Las Vegas, NV
Frank Daskalos Frank is an Alzheimer’s patient in Dr. Farlow’s clinical trial, Indiana University
Indianapolis, IN
Helene DeCoste Patient in Dr. Reisa Sperling’s prevention trial, the A4 Study, Harvard Medical School
Boston, MA
Anna Defelice Daughter of Pasquale Roccio.
Indianapolis, IN
Ronald DeMattos Distinguished Resident Fellow, Chief Scientific Officer, Neurobiologicals Eli Lilly and Company
Indianapolis, IN
Dr. Martin Farlow Professor of Neurology, Vice Chairman of Research, Neurology Dept., Assoc. Director, Indiana Alzheimer’s Disease Center
Indianapolis, IN
Phyllis Ferrell VP, Alzheimer’s Disease Platform Team Leader Eli Lilly and Company
Indianapolis, IN
Paula Garrett Senior Director, Enterprise Website Leader Eli Lilly and Company
Indianapolis, IN
Margaret Hamburg Former Commissioner, FDA
Washington, DC
Dr. Harald Hampel Professor AX-UPMC Chair at Pierre and Marie Curie University, Sorbonne Universities
Paris, France
Janice Hitchcock Advisor, Regulatory Affairs, Eli Lilly and Company
Indianapolis, IN
Richard Hodes Director, National Institute on Aging, NIH
Washington, DC
David M. Holtzman, M.D. Chairmain of Department of Neurology Washington University
St. Louis, MO
Ron Insana Financial News Correspondent, CNBC
New York, NY
Delia Kelly Delia's late husband was an Alzheimer's patient of Dr. Salloway and donated his brain to Salloway’s study.
Providence, RI
John Klein Chairman & CEO of Cambridge Therapeutic Technologies
Cambridge, MA
John Lechleiter Former President, Chief Executive Officer and Chairman of the Board of Directors, Eli Lilly and Company
Indianapolis, IN
Jeremy Levin Chairman of the Board of Directors and CEO, Ovid Therapeutics
New York, NY
Hong Liu-Seifert Senior Research Advisor, Statistics, Eli Lilly and Company
Indianapolis, IN
Ed Markey Senator, Massachusetts
Boston, MA
Patrick May Former Senior Research Fellow Neuroscience Discovery Research Eli Lilly and Company
Indianapolis, IN
Dr. Lefkos Middleton Professor of Neurology, School of Public Health, Imperial College of London
London, England
Jeff Myers CEO, Medicaid Health Plans of America
San Francisco, CA
Stelios Papadopoulos Chairman of the Board, Biogen Inc.
Cambridge, MA
Dr. Ron Peterson Director, Mayo Clinic Alzheimer's Disease Research Center and the Mayo Clinic Study of Aging
Rochester, MN
David Ricks Chairman, President and CEO, Eli Lilly and Company
Indianapolis, IN
Pasquale Rocchio Patient in Dr Martin Farlow’s research study.
Indianapolis, IN
Sharon Rocchio Wife of Pasquale Roccio.
Indianapolis, IN
Dr. Marwan Sabbagh Karsten Solheim Chair for Dementia, Professor of Neurology, Director of the Alzheimer’s and Memory Disorders Division, Barrow Neurological Institute
Phoenix, AZ
Dr. Stephen Salloway Professor of Neurology and Psychiatry, Brown University
Providence, RI
Dr. Dennis Selkoe Co-Director, The Ann Romney Center for Neurological Diseases; Chief Division of Basic Neuroscience Researchm Vincent and Stella Coates Professor of Neurological Diseases, Brigham and Women’s Hospital, Harvard Medical School
Boston, MA
Eric Siemers Distinguished Medical Fellow, Alzheimer’s Disease Team, Eli Lilly and Company
Indianapolis, IN
Dan Skovronsky Founder and CEO, Avid Radiopharmaceuticals, Inc, Eli Lilly and Company
Philadelphia, PA
Dr. Reisa Sperling Professor of Neurology; Director, Center for Alzheimer’s Research & Treatment. Brigham and Women’s Hospital, Harvard Medical School
Boston, MA
Karen L. Sundell Principal Research Scientist, Alzheimer’s Disease Team, Eli Lilly and Company
Indianapolis, IN
Olga Susi is 102 and an Alzheimer's patient in Dr. Salloway's research study.
Providence, RI
Dr. Rudy Tanzi Joseph P. and Rose F. Kennedy Professor of Neurology, Harvard Medical School; Vice- Chair, Neurology, Massachusetts General Hospital
Boston, MA
Meg Tirrell Reporter, CNBC
New York,NY
Neil deGrasse Tyson Astrophysicist, Cosmologist Frederick P. Rose Director of the Hayden Planetarium
Los Angeles, CA
George Vradenburg Chairman, Us Against Alzheimer’s
Washington, DC
Tony Ware Senior Vice President, Product Development, Eli Lilly and Company
Indianapolis, IN
Dr. Michael Weiner Professor of Radiology and Biomedical Imaging, Medicine, Psychiatry, and Neurology, UCSF
San Francisco, CA

FILMMAKERS

Director/Producer:

Executive Producers:

Supervising Producers:

Cinematographers:

Editors:

Original Score:

TAKE ACTION AGAINST ALZHEIMER'S!

1 in 2 Americans over the age of 85 develop Alzheimer's. This disease will affect us all.

YOU CAN ACT NOW!

JOIN A RESEARCH STUDY

Participate in a clinical trial near you.


DONATE $10 TO RESEARCH

Text TPMOVIE to 50555 to support research and learn more about Alzheimer's disease.


TAKE A WALK!

Studies show that a 45-minute brisk walk 3x per week can improve brain health.


HOST A SCREENING OF TURNING POINT

Help mobilize awareness and raise funds for your organization or community.

FIND A SCREENING




loading

GALLERY

MEDIA

Turning Point Wins 3 Awards at the Boston Film Festival, Including Best Documentary Film
BOSTON FILM FESTIVAL
9/26/2018

Turning Point to screen at the Austin Film Festival
THE HOLLYWOOD REPORTER
9/25/2018

Turning Point: A Panel Conversation on the Documentary
THE ATLANTIC LIVE
9/17/2018

Turning Point to screen at the Heartland Film Festival
INDIANAPOLIS STAR
9/14/2018

The Search for an Alzheimer’s Turning Point: Powerful lessons in a new documentary about a failed Alzheimer's trial
ANTIDOTE
5/16/2018

Nashville Film Festival Puts a Spotlight on Region’s Diversity
VARIETY
5/10/2018

Newport Beach Film Festival: Take 19
NEWPORT BEACH INDY
4/27/2018

The 49th Annual Nashville Film Festival Announces The 2018 Documentary Special Presentations
BROADWAY WORLD
4/5/2018

PARTNERS

BrightFocus funds research & educates the public about Alzheimer's disease, macular degeneration, and glaucoma. Learn about these diseases and how you can help find a cure.

Volunteers of America has helped America's most vulnerable for over 120 years. Get help, find local offices, give support, and learn more about us.